PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP)
CUSIP: 69353Y103
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 53,185,766
- Total 13F shares
- 40,492,185
- Share change
- -2,251,786
- Total reported value
- $65,594,864
- Put/Call ratio
- 25%
- Price per share
- $1.62
- Number of holders
- 91
- Value change
- -$3,771,661
- Number of buys
- 44
- Number of sells
- 55
Quarterly Holders Quick Answers
What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 69353Y103:
Top shareholders of PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
12%
|
6,475,291
|
$11,007,995 | — | 31 Mar 2024 | |
| INTERWEST PARTNERS X LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,502,480
|
$10,040,531 | — | 13 Jul 2021 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
6%
|
3,198,756
|
$5,437,885 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.8%
|
3,110,309
|
$5,287,525 | — | 31 Mar 2024 | |
| Euclidean Capital LLC |
13F
3/4/5
|
Company · 10%+ Owner |
4.9%
|
2,627,643
|
$4,466,993 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.6%
|
2,452,111
|
$4,168,589 | — | 31 Mar 2024 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
4.4%
|
2,345,361
|
$3,987,113 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
3.9%
|
2,080,194
|
$3,533,000 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3%
|
1,580,550
|
$2,686,935 | — | 31 Mar 2024 | |
| Thilo Schroeder |
3/4/5
|
Director |
—
class O/S missing
|
1,101,283
|
$2,455,861 | — | 06 Oct 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
2.6%
|
1,367,915
|
$2,325,455 | — | 31 Mar 2024 | |
| BML Capital Management, LLC |
13F
|
Company |
2.5%
|
1,306,490
|
$2,221,033 | — | 31 Mar 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
2.4%
|
1,275,462
|
$2,168,285 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.1%
|
1,095,250
|
$1,861,925 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
903,137
|
$1,535,498 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.6%
|
826,704
|
$1,405,397 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
785,990
|
$1,336,183 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.4%
|
720,635
|
$1,225,079 | — | 31 Mar 2024 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
1.3%
|
675,000
|
$1,147,500 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.2%
|
655,461
|
$1,114,284 | — | 31 Mar 2024 | |
| EcoR1 Capital, LLC |
13F
|
Company |
1.1%
|
566,879
|
$963,694 | — | 31 Mar 2024 | |
| PERSONAL CFO SOLUTIONS, LLC |
13F
|
Company |
1%
|
550,342
|
$935,581 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.98%
|
522,723
|
$888,629 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.93%
|
493,550
|
$839,036 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
0.89%
|
471,481
|
$802,130 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.82%
|
433,853
|
$737,550 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.79%
|
421,828
|
$717,109 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.75%
|
399,710
|
$679,507 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.69%
|
365,400
|
$621,180 | — | 31 Mar 2024 | |
| Acuitas Investments, LLC |
13F
|
Company |
0.66%
|
351,875
|
$598,188 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.64%
|
338,134
|
$574,828 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.61%
|
322,024
|
$547,441 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.51%
|
272,859
|
$463,861 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.5%
|
265,924
|
$452,071 | — | 31 Mar 2024 | |
| M&T BANK CORP |
13F
|
Company |
0.49%
|
258,484
|
$439,711 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.39%
|
205,855
|
$349,954 | — | 31 Mar 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.38%
|
200,938
|
$341,595 | — | 31 Mar 2024 | |
| Shay Capital LLC |
13F
|
Company |
0.37%
|
197,178
|
$335,203 | — | 31 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.37%
|
195,006
|
$331,510 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.29%
|
152,959
|
$260,031 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.29%
|
152,391
|
$259,065 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.27%
|
141,788
|
$241,039 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.25%
|
133,624
|
$227,161 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.25%
|
131,845
|
$224,137 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.22%
|
119,269
|
$202,757 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
117,101
|
$199,072 | — | 31 Mar 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.22%
|
114,975
|
$195,458 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.22%
|
114,432
|
$194,534 | — | 31 Mar 2024 | |
| FISHMAN JAY A LTD/MI |
13F
|
Company |
0.15%
|
80,000
|
$136,000 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
75,000
|
$127,500 | — | 31 Mar 2024 |
Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q2 2024
As of 30 Jun 2024,
PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,492,185 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ArrowMark Colorado Holdings LLC, Sio Capital Management, LLC, Euclidean Capital LLC, ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, CITADEL ADVISORS LLC, BML Capital Management, LLC, and PFM Health Sciences, LP.
This page lists
91
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
96
Q2 2024 holders
91
Holder diff
-5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.